
|Articles|May 1, 2010
- Pharmaceutical Executive-05-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2010
One Pill Makes You Better?
Advertisement
Articles in this issue
about 16 years ago
Weathering the Compliance Stormabout 16 years ago
Pharma's Orphansabout 16 years ago
Tech Toys 2: Revenge of the Appabout 16 years ago
Five Policies for Pharma's Big 50about 16 years ago
Healthcare Hung Up in the UK Election?about 16 years ago
How to Become a Commitment Catalyst?about 16 years ago
Pharma's Big TradeoffAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
Pharmaceutical Executive Daily: FDA Approves Datroway
5




